Skip to content

Your Health, Your Way

Stay Informed on What Matters to You

Daily-updated information from NIH, CDC, FDA, and ClinicalTrials.gov — in plain English for people managing real conditions.

Updated every morning. Sources linked. No sponsored content.

Condition Hub

Bladder Health & Incontinence

Evidence-based information on bladder control, incontinence types, treatments, and daily management strategies.

Affects over 33 million Americans. Highly treatable with the right support.

View latest updates
Condition Hub

Type 2 Diabetes & Pre-Diabetes

Up-to-date guidance on blood sugar management, medications, lifestyle, and preventing complications.

37 million Americans have diabetes. Another 96 million have pre-diabetes.

View latest updates
Condition Hub

High Blood Pressure

Plain-English updates on blood pressure management, medications, lifestyle changes, and risk reduction.

Nearly half of American adults have high blood pressure.

View latest updates
Condition Hub

Chronic Kidney Disease

News and guidance on CKD stages, slowing progression, dialysis options, and kidney-friendly living.

37 million Americans live with CKD, many without knowing it.

View latest updates
Condition Hub

Heart Disease & High Cholesterol

The latest on heart disease prevention, cholesterol management, cardiac medications, and cardiovascular health.

Heart disease is the #1 cause of death in the United States.

View latest updates
Condition Hub

IBD — Crohn's & Ulcerative Colitis

News on Crohn's disease and ulcerative colitis — treatments, biologics, flare management, and emerging research.

3 million Americans live with IBD.

View latest updates
Condition Hub

Pre-Diabetes

Practical guidance on reversing pre-diabetes — understanding A1C ranges, lifestyle interventions, metformin, GLP-1 prevention, and how to stop progression to type 2 diabetes.

96 million American adults have pre-diabetes. 8 in 10 don't know it. With the right steps, it's largely reversible.

View latest updates
Condition Hub

hATTR Amyloidosis

Hereditary transthyretin (hATTR) amyloidosis is a rare genetic disease where abnormal TTR protein builds up in nerves and the heart. New RNA-based therapies have transformed outcomes — but early diagnosis is critical.

hATTR affects an estimated 50,000 people worldwide. Most go undiagnosed for years due to overlapping symptoms with common conditions.

View latest updates
Condition Hub

Primary Biliary Cholangitis (PBC)

PBC is a rare autoimmune liver disease that slowly destroys bile ducts. With ursodiol and newer second-line therapies, most patients can halt progression and live normal lives — if caught early.

PBC affects roughly 1 in 1,000 women over 40. It's often discovered incidentally on routine liver enzyme tests.

View latest updates
Condition Hub

Pulmonary Arterial Hypertension (PAH)

PAH is a rare and serious condition where high pressure in the lung's arteries strains the right heart. Targeted combination therapies have dramatically extended survival — but the disease still requires expert management.

PAH affects 15–50 people per million. Women are diagnosed 3× more often than men. Early treatment initiation is the strongest predictor of long-term outcomes.

View latest updates
Condition Hub

ALS (Amyotrophic Lateral Sclerosis)

🧠

ALS is a progressive neurodegenerative disease affecting the nerve cells controlling muscle movement. While there is no cure, new treatments are extending survival and improving quality of life for people living with ALS.

About 5,000 Americans are diagnosed with ALS each year. The Ice Bucket Challenge in 2014 raised over $220 million for research and directly funded the discovery of new ALS genes.

View latest updates
Condition Hub

Pregnancy & Maternal Health

Evidence-based guidance on pregnancy complications, prenatal health, gestational diabetes, preeclampsia, postpartum recovery, and maternal mental health — in plain English.

Nearly 4 million babies are born in the U.S. each year. Complications affect 1 in 4 pregnancies. The U.S. has the highest maternal mortality rate among high-income nations.

View latest updates

SOURCES WE MONITOR DAILY

NIH / MedlinePlusCDCFDA MedWatchFDA NewsClinicalTrials.gov

All content links back to the original government source. No sponsored content.